From the Thoraxcenter, Erasmus University and University Hospital Dijkzigt, Rotterdam, the Netherlands suMMARY Percutaneous transluminal coronary angioplasty has been advocated as a mandatory procedure to prevent reocclusion after successful thrombolysis in acute myocardial infarction. This study describes our experience with both procedures over a 12 month period. Out of 105 patients catheterised in the acute phase of myocardial infarction, 64 were recanalised with 250 000 units of streptokinase, while in 25 patients recanalisation could not be achieved. In the remaining 16 , the infarct related vessel was patent at the time of the procedure. Eighteen of the 78 patients who had a patent infarct related vessel at the end of the recanalisation procedure underwent transluminal angioplasty immediately afterwards. Post lysis angiograms were analysed quantitatively with a computerised measurement system. The contours of the relevant arterial segments were detected automatically. Reference diameter, minimal obstruction diameter, length of the lesions, and percentage diameter stenosis were averaged from multiple views.
In 31% of our patients a diameter stenosis ofless than 5O0/o was found whereas one of 70% or more was seen in only 19%. Eleven stenotic lesions, recanalised at the acute stage, reoccluded in the short term, and in the long term eight other patients sustained a reinfarction in the same myocardial territory. Seventeen of these 19 recanalised lesions had a diameter stenosis of 580/o or more. In view of these results, we felt justified in combining recanalisation and angioplasty in 18 patients selected from the most recent admissions. In these patients, the mean diameter stenosis decreased from 590/o to 30% and mean pressure gradient from 41 to successfully treated cases, we used a balloon catheter with an outer diameter of 3.7 mm, in the 14 other patients its outer diameter was 3 mm. The mean pressure gradient across the stenotic lesion was computed on line after 20 seconds of data acquisition. Two to nine (mean 4-5; SD 2.3) balloon inflations were performed for a period of 10 to 70 seconds (mean 49; SD 12) at a pressure of 4 to 8 bar (mean 6; SD 1). After the dilatation procedure the sheath was left in place for the next 24 hours, while the patients were monitored in the coronary care unit.
All patients received heparin (20 000 U/24h) followed by oral coumarin until discharge from the hospital. Anticoagulants were continued after discharge in patients with left ventricular aneurysm or recognised mural thrombus in the left ventricle. In addition, nifedipine, 10 mg every four hours, was given for two days in patients treated with streptokinase.12
QUANTITATIVE ANGIOGRAPHIC ANALYSIS
The quantitative analysis of selected coronary segments was carried out with the help of a computer based coronary angiography analysis system, which has been described extensively elsewhere. ' The angiographic findings at the beginning and at the end of the recanalisation procedure are given in Fig.  2 . In 64 patients, thrombolysis was successful and after recanalisation transluminal angioplasty was performed in 18 of these 64 patients. In 16 other patients the infarct related vessel was found to be patent at the first coronary angiogram. In two of the 16 cases, occlusion of an initially patent artery occurred during the procedure. Thus, 78 infarct related vessels were patent at the end of the catheterisation procedure. In 25 patients we did not succeed in recanalising the thrombosed arteries.
Fifty seven patients, excluding those who had undergone percutaneous transluminal coronary angioplasty in the acute phase, agreed to have further angiograms two weeks later (Fig. 3) . In 41 patients, the infarct related vessel was still patent. Five lesions which had remained occluded at the acute stage were found to be recanalised at this point; in seven other patients the coronary arteries which had been successfully recanalised at the acute stage were now found to be reoccluded. This The percentage diameter stenosis of eight recanalised lesions in patients who initially underwent a successful recanalisation and subsequently sustained a reinfarction in the same myocardial territory is shown in Fig. 7 . Six of eight stenotic lesions had a percentage diameter stenosis greater than or equal to 58% (the median value) immediately after thrombolysis. The second column represents 11 stenotic lesions which reoccluded at the acute stage (n=4) or at the chronic stage (n=7) after they had been recanalised. All of them had a percentage diameter stenosis greater than or equal to 58%. The diameter stenoses of 14 stenotic lesions found to be patent at the first coronary angiogram during the acute phase of their myocardial infarction are also given. Nine of them had a diameter stenosis less than 580/o (median value).
From these data it appeared that reocclusion and recurrent myocardial infarction were more frequent in patients with a stenosis greater than 58% in diameter after recanalisation. The angiographic results of the combined procedure performed in 18 patients are also shown. Though the selection and decision to perform angioplasty had been based on a visual evaluation of the severity of the lesion at the time of the procedure, it appears retrospectively that 13 of the 18 lesions had a stenosis greater than 58% in diameter after thrombolysis. In these 18 patients angioplasty decreased the average percentage diameter stenosis from 590/o (SD: 9.9%) to 300/o (SD: 9.9%) and the minimal obstruction diameter increased from 1-3 mm (SD: 04 mm) to 2-2 mm (SD: 0-3 mm). This reduction in diameter stenosis was highly significant (p<00001) and was associated with a significant decrease in mean pressure gradient from 41 mmHg (SD: 17 mmHg) to 8 mmHg (SD: 5 mmHg) (Fig.8) . On restudied angiographically after a mean follow up of four months (range from 10 days to 11 months). In all but one the dilated vessel was patent. One patient developed exertional angina three months later. A restenosis at the site of the previous occlusion was successfully dilated a second time.
Discussion
In this paper it is shown that intracoronary streptokinase infusion and percutaneous transluminal coronary angioplasty can be carried out in the same session in an effort to enhance reperfusion. The issue, however, is not whether these combined interventions can be performed safely in the setting of acute infarction, but rather whether one is justified in doing so.
The present work is a tentative answer to this question and its conclusions are based on the results of quantitative angiographic analysis of recanalised vessels.
Since at the end of the procedure, 31% of our patients had a recanalised vessel with percentage diameter stenosis below 50%/o, whereas a diameter stenosis greater than 50%/o was seen in the remainder, we had no evidence of a major residual thrombus at the site of the stenosis. No retention of contrast medium or staining of a distal thrombus was seen, so residual clot, reported by others,16-18 appears unlikely as well. Furthermore it has been the custom to continue the streptokinase treatment for about 30 minutes after patency has already been established. Is transluminal coronary angioplasty mandatory after successful thrombolysis?
On the other hand, severe residual stenosis of the recanalised vessel has been reported by other groups.'0'9 Their reports are based on visual and therefore subjective interpretation of the stenotic lesions. Overestimation and excessive variations by intra-or interobserver error have been reported. 20 21 These discrepancies led us to evaluate the exact condition of the stenotic lesions after successful lysis by an objective, computer aided, interpretation. This method has been validated not only with copper and perspex models filled with contrast medium but also from necropsy studies. [22] [23] [24] In 14 cases with clear clinical, electrocardiographic, and enzymatic signs of an acute infarction, the diseased vessel was patent at the time of coronary angiography. In these patients long lasting vasospasm superimposed on organic lesions may have led to transient occlusion and myocardial infarction. 25 26 Another possibility is that the clot had already lysed in the meantime. In nine out of these 14 patients, the infarct related vessel had a mild stenotic lesion, a factor that might have facilitated the reopening of the vessel. This is the more likely as these patients were started on an intravenous perfusion of glyceryl trinitrate before intracoronary lysis was attempted. In patients with transmural acute myocardial infarction and coronary arterial thrombi, histological sections of coronary arteries have been shown to be narrowed by the atherosclerotic plaque alone from 33 to 98% (mean 81%) at the site of the thrombus. 27 When histological cross-sectional areas are compared with crosssectional-areas derived from diameter measurements, our quantitative angiographic results in vivo are consistent with the histological findings. Furthermore, it is remarkable how closely the obstruction diameters after successful thrombolysis correspond with the postmortem findings reported by Fulton,28 as shown in Fig. 9 . In one third of our patients the myocardial infarction had occurred when the relevant artery showed a stenosis of less than 5O0/o. Gertz et al.29 have shown experimentally that endothelial damage and thrombus formation may occur at the site of focal Obstruction diameter otter thrombolysis arterial constriction even when the reduction in luminal diameter by itself is insufficient to alter significantly the rate of flow.
As shown by Fulton28 in his elegant study on the morphology of coronary thrombotic occlusions, atherosclerotic lesions are usually of a complex nature. In two thirds of his cases, a break or a tear in the luminal lining exposed blood flowing to the material composing the underlying lesion. He postulated that this was the probable cause of platelet aggregation and fibrin deposition.303' In half of his cases, a haemorrhagic dissection was found which resulted in an apparent reduction of the lumen. Successful thrombolysis could again expose the material of the atheromatous lesion to flowing blood.
Whether the thrombogenic activity of this material would be as active as it was in the first instance remains speculative but secondary thrombotic occlusion may occur. Accordingly, there are strong theoretical reasons for adopting antithrombotic measures after successful thrombolysis. On the other hand, Kooijman, Reiber, Hugenholtz observations that during streptokinase infusion, recocclusion occurred in four patients (Fig. 7) despite intravenous or intracoronary administration of glyceryl trinitrate or nifedipine. Here percutaneous transluminal coronary angioplasty might have been the only way to restore blood flow adequately and to prevent immediate reocclusion. As emphasised by Meyer et al. I I the advantages of the combined procedure are savings in time and money. The same introducing sheath can be used, the catheterisation laboratory equipment and the personnel have to be used only once, and it appears to be less exacting for the patient. To date no reocclusions have occured during such immediate dilation of the critical stenosis. Fifteen out of the 18 patients who underwent percutaneous transluminal coronary angioplasty were restudied angiographically after a median follow up of four months (range from 10 days to 11 months). In all but one patient, the dilated vessel has remained patent. All 17 patients have been followed at the outpatient clinic at three month intervals. The mean period of follow up has been seven months and the longest one year. None of these patients has sustained a reinfarction thus far.
These observations indicate that percutaneous transluminal coronary angioplasty immediately after thrombolysis is a safe and reasonable procedure when after lysis of the obstruction a 58% stenosis is still present. This combined approach seems to result in a lower rate of reocclusion or reinfarction than thrombolysis alone. As further randomised trials are necessary to show the ultimate benefit of thrombolysis in acute myocardial infarction, it is recommended that during them the additional value of immediate percutaneous transluminal coronary angioplasty is investigated.
